Cleared Traditional

K883847 - DERATA MEDI-JECTOR V

K883847 is an FDA 510(k) clearance for DERATA MEDI-JECTOR V, manufactured by Derata Corp.. The device is a Class 2 General Hospital device with product code KZE cleared through the Traditional 510(k) pathway after a 49-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1988
Decision
49d
Days
Class 2
Risk

K883847 is an FDA 510(k) clearance for the DERATA MEDI-JECTOR V. Classified as Injector, Fluid, Non-electrically Powered (product code KZE), Class II - Special Controls.

Submitted by Derata Corp. (Minneapolis, US). The FDA issued a Cleared decision on October 31, 1988 after a review of 49 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5430 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K883847

510(k) Number K883847 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 12, 1988
Decision Date October 31, 1988
Days to Decision 49 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
80d faster than avg
Panel avg: 129d · This submission: 49d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KZE Device Classification - Class 2, Special Controls

Product Code KZE Injector, Fluid, Non-electrically Powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5430
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - KZE Injector, Fluid, Non-electrically Powered

All 52
Devices cleared under the same product code (KZE) and FDA review panel - the closest regulatory comparables to K883847.
INJECTOR, INSULIN
K905062 · Sound 2000 Medical Systems, Inc. · Mar 1991
VITAJET(INSULIN JET INJECTION DEVICE)
K893215 · Vitajet Industriae Comercioltda. · May 1990
J-TIP INJECTOR SYSTEM
K884293 · California Medical Innovations, Inc. · Jan 1989
ROBINJECT
K864984 · International Medical Products, Inc. · Jun 1987
BIOJECTOR SYRINGE SYSTEM
K861687 · Bioject, Inc. · Apr 1987
DERATA MEDI-JECTOR IV
K864561 · Derata Corp. · Feb 1987